145 related articles for article (PubMed ID: 31453292)
1. Effect of parental origin of damaging variants in pro-angiogenic genes on fetal growth in patients with congenital heart defects: Data and analyses.
Russell MW; Moldenhauer JS; Rychik J; Burnham NB; Zullo E; Parry SI; Simmons RA; Elovitz MA; Nicolson SC; Linn RL; Johnson MP; Yu S; Sampson MG; Hakonarson H; Gaynor JW
Data Brief; 2019 Aug; 25():104311. PubMed ID: 31453292
[TBL] [Abstract][Full Text] [Related]
2. Damaging Variants in Proangiogenic Genes Impair Growth in Fetuses with Cardiac Defects.
Russell MW; Moldenhauer JS; Rychik J; Burnham NB; Zullo E; Parry SI; Simmons RA; Elovitz MA; Nicolson SC; Linn RL; Johnson MP; Yu S; Sampson MG; Hakonarson H; Gaynor JW
J Pediatr; 2019 Oct; 213():103-109. PubMed ID: 31227283
[TBL] [Abstract][Full Text] [Related]
3. Placental vascular malperfusion lesions in fetal congenital heart disease.
Leon RL; Sharma K; Mir IN; Herrera CL; Brown SL; Spong CY; Chalak LF
Am J Obstet Gynecol; 2022 Oct; 227(4):620.e1-620.e8. PubMed ID: 35609643
[TBL] [Abstract][Full Text] [Related]
4. The placenta as the window to congenital heart disease.
Cohen JA; Rychik J; Savla JJ
Curr Opin Cardiol; 2021 Jan; 36(1):56-60. PubMed ID: 33074934
[TBL] [Abstract][Full Text] [Related]
5. Placental delayed villous maturation is associated with fetal congenital heart disease.
O'Hare CB; Mangin-Heimos KS; Gu H; Edmunds M; Bebbington M; Lee CK; He M; Ortinau CM
Am J Obstet Gynecol; 2023 Feb; 228(2):231.e1-231.e11. PubMed ID: 35985515
[TBL] [Abstract][Full Text] [Related]
6. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study.
Lord J; McMullan DJ; Eberhardt RY; Rinck G; Hamilton SJ; Quinlan-Jones E; Prigmore E; Keelagher R; Best SK; Carey GK; Mellis R; Robart S; Berry IR; Chandler KE; Cilliers D; Cresswell L; Edwards SL; Gardiner C; Henderson A; Holden ST; Homfray T; Lester T; Lewis RA; Newbury-Ecob R; Prescott K; Quarrell OW; Ramsden SC; Roberts E; Tapon D; Tooley MJ; Vasudevan PC; Weber AP; Wellesley DG; Westwood P; White H; Parker M; Williams D; Jenkins L; Scott RH; Kilby MD; Chitty LS; Hurles ME; Maher ER;
Lancet; 2019 Feb; 393(10173):747-757. PubMed ID: 30712880
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of placental neuropilin-1 in fetal growth restriction.
Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
[TBL] [Abstract][Full Text] [Related]
8. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
Yagel S; Cohen SM; Goldman-Wohl D
Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal changes in fetal head biometry and fetoplacental circulation in fetuses with congenital heart defects.
Ordás P; Rodríguez R; Herrero B; Deiros L; Gómez E; Llurba E; Bartha JL; Antolín E
Acta Obstet Gynecol Scand; 2022 Sep; 101(9):987-995. PubMed ID: 35726340
[TBL] [Abstract][Full Text] [Related]
10. Maternal biomarkers for fetal heart failure in fetuses with congenital heart defects or arrhythmias.
Miyoshi T; Hosoda H; Nakai M; Nishimura K; Miyazato M; Kangawa K; Ikeda T; Yoshimatsu J; Minamino N
Am J Obstet Gynecol; 2019 Jan; 220(1):104.e1-104.e15. PubMed ID: 30273582
[TBL] [Abstract][Full Text] [Related]
11. Factors related to fetal demise in cases with congenital heart defects.
Snoep MC; Bet BB; Zwanenburg F; Knobbe I; Linskens IH; Pajkrt E; Rozendaal L; Van der Meeren LE; Clur SA; Haak MC
Am J Obstet Gynecol MFM; 2023 Aug; 5(8):101023. PubMed ID: 37220848
[TBL] [Abstract][Full Text] [Related]
12. In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.
Laurent L; Huang C; Ernest SR; Berard A; Vaillancourt C; Hales BF
Birth Defects Res A Clin Mol Teratol; 2016 Dec; 106(12):1044-1055. PubMed ID: 27384265
[TBL] [Abstract][Full Text] [Related]
13. Placenta morphology and biomarkers in pregnancies with congenital heart disease - A systematic review.
Snoep MC; Aliasi M; van der Meeren LE; Jongbloed MRM; DeRuiter MC; Haak MC
Placenta; 2021 Sep; 112():189-196. PubMed ID: 34388551
[TBL] [Abstract][Full Text] [Related]
14. Markers of placental function correlate with prevalence and quantity of nucleated fetal cells in maternal circulation in normotensive term pregnancies.
Fjeldstad HE; Jacobsen DP; Johnsen GM; Sugulle M; Chae A; Kanaan SB; Gammill HS; Staff AC
Acta Obstet Gynecol Scand; 2023 Jun; 102(6):690-698. PubMed ID: 36933003
[TBL] [Abstract][Full Text] [Related]
15. The cardiac-fetal-placental unit: fetal umbilical vein flow rate is linked to the maternal cardiac profile in fetal growth restriction.
Valensise H; Farsetti D; Pometti F; Vasapollo B; Novelli GP; Lees C
Am J Obstet Gynecol; 2023 Feb; 228(2):222.e1-222.e12. PubMed ID: 35944606
[TBL] [Abstract][Full Text] [Related]
16. Maternal and foetal angiogenic imbalance in congenital heart defects.
Llurba E; Sánchez O; Ferrer Q; Nicolaides KH; Ruíz A; Domínguez C; Sánchez-de-Toledo J; García-García B; Soro G; Arévalo S; Goya M; Suy A; Pérez-Hoyos S; Alijotas-Reig J; Carreras E; Cabero L
Eur Heart J; 2014 Mar; 35(11):701-7. PubMed ID: 24159191
[TBL] [Abstract][Full Text] [Related]
17. Neuroplacentology in congenital heart disease: placental connections to neurodevelopmental outcomes.
Leon RL; Mir IN; Herrera CL; Sharma K; Spong CY; Twickler DM; Chalak LF
Pediatr Res; 2022 Mar; 91(4):787-794. PubMed ID: 33864014
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation profiles of genes associated with angiogenesis in the samples of placenta in pregnancies complicated by intrauterine growth restriction.
Selcen Cebe F; Nur Tola E; Aslan Koşar P; Oral B
J Matern Fetal Neonatal Med; 2021 Sep; 34(17):2854-2862. PubMed ID: 31581866
[TBL] [Abstract][Full Text] [Related]
19. An endocrine model for the diagnosis of intrauterine growth retardation as demonstrated by the determination of total estrogen and pregnandiol 24-hour urinary excretion in 222 at risk pregnancies.
Wolfrum R; Bordasch C; Holweg J
J Perinat Med; 1975; 3(4):248-59. PubMed ID: 1225959
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum placental growth factor at 11-13 weeks' gestation and fetal cardiac defects.
Llurba E; Syngelaki A; Sánchez O; Carreras E; Cabero L; Nicolaides KH
Ultrasound Obstet Gynecol; 2013 Aug; 42(2):169-74. PubMed ID: 23151971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
